7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Obalon Therapeutics, Inc
(:OBLN) 

OBLN stock logo

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprise...

Full Time Employees: 2
Sector: Healthcare
Industry: Medical Devices

Share this website to your friends
Obalon Therapeutics Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.727.4411.1614.8818.622.3226.04Thousand
Obalon Therapeutics Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.643.294.936.588.229.8611.51Thousand
Obalon Therapeutics Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.486.9610.4413.9217.3920.8724.35Thousand
Obalon Therapeutics Op Cashflow Per Share ttm
202208 202209 202210 202211 202212 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.34-1.15-0.96-0.77-0.57-0.38-0.190
Obalon Therapeutics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.36-1.17-0.97-0.78-0.58-0.39-0.190
Obalon Therapeutics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.611.221.822.433.043.654.25
Obalon Therapeutics P/S ratio ttm
202208 202209 202210 202211 202212 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.837.6511.4815.319.1322.9526.78Milllion
Obalon Therapeutics (GAAP) P/E ratio ttm
202208 202209 202210 202211 202212 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.08-3.5-2.92-2.33-1.75-1.17-0.580
Obalon Therapeutics P/B ratio ttm
202208 202209 202210 202211 202212 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.731.452.182.93.634.355.08
No extra charts and metrics for this ticker.